245 related articles for article (PubMed ID: 18088570)
21. New insights into ocular blood flow at very high altitudes.
Bosch MM; Merz TM; Barthelmes D; Petrig BL; Truffer F; Bloch KE; Turk A; Maggiorini M; Hess T; Schoch OD; Hefti U; Sutter FK; Pichler J; Huber A; Landau K
J Appl Physiol (1985); 2009 Feb; 106(2):454-60. PubMed ID: 19057000
[TBL] [Abstract][Full Text] [Related]
22. Cerebral blood flow at high altitude.
Ainslie PN; Subudhi AW
High Alt Med Biol; 2014 Jun; 15(2):133-40. PubMed ID: 24971767
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema.
Hopkins SR; Garg J; Bolar DS; Balouch J; Levin DL
Am J Respir Crit Care Med; 2005 Jan; 171(1):83-7. PubMed ID: 15486339
[TBL] [Abstract][Full Text] [Related]
24. Effects of high altitude exposure on cerebral hemodynamics in normal subjects.
Van Osta A; Moraine JJ; Mélot C; Mairbäurl H; Maggiorini M; Naeije R
Stroke; 2005 Mar; 36(3):557-60. PubMed ID: 15692117
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary function and hypoxic ventilatory response in subjects susceptible to high-altitude pulmonary edema.
Selland MA; Stelzner TJ; Stevens T; Mazzeo RS; McCullough RE; Reeves JT
Chest; 1993 Jan; 103(1):111-6. PubMed ID: 8417862
[TBL] [Abstract][Full Text] [Related]
26. Cerebral blood flow response to acute hypoxic hypoxia.
Harris AD; Murphy K; Diaz CM; Saxena N; Hall JE; Liu TT; Wise RG
NMR Biomed; 2013 Dec; 26(12):1844-52. PubMed ID: 24123253
[TBL] [Abstract][Full Text] [Related]
27. Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia.
Teppema LJ; Balanos GM; Steinback CD; Brown AD; Foster GE; Duff HJ; Leigh R; Poulin MJ
Am J Respir Crit Care Med; 2007 Feb; 175(3):277-81. PubMed ID: 17095745
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness.
Kallenberg K; Bailey DM; Christ S; Mohr A; Roukens R; Menold E; Steiner T; Bärtsch P; Knauth M
J Cereb Blood Flow Metab; 2007 May; 27(5):1064-71. PubMed ID: 17024110
[TBL] [Abstract][Full Text] [Related]
29. Cerebral vasomotor reactivity at high altitude in humans.
Jansen GF; Krins A; Basnyat B
J Appl Physiol (1985); 1999 Feb; 86(2):681-6. PubMed ID: 9931208
[TBL] [Abstract][Full Text] [Related]
30. [Cardiac response to hypoxia and susceptibility to mountain sickness].
Richalet JP; Kéromès A; Carillion A; Mehdioui H; Larmignat P; Rathat C
Arch Mal Coeur Vaiss; 1989 Aug; 82 Spec No 2():49-54. PubMed ID: 2510693
[TBL] [Abstract][Full Text] [Related]
31. Cerebral pressure-flow and metabolic responses to sustained hypoxia: effect of CO2.
Yang SP; Bergö GW; Krasney E; Krasney JA
J Appl Physiol (1985); 1994 Jan; 76(1):303-13. PubMed ID: 8175522
[TBL] [Abstract][Full Text] [Related]
32. AltitudeOmics: cerebral autoregulation during ascent, acclimatization, and re-exposure to high altitude and its relation with acute mountain sickness.
Subudhi AW; Fan JL; Evero O; Bourdillon N; Kayser B; Julian CG; Lovering AT; Panerai RB; Roach RC
J Appl Physiol (1985); 2014 Apr; 116(7):724-9. PubMed ID: 24371013
[TBL] [Abstract][Full Text] [Related]
33. Changes in cerebral blood flow and vasoreactivity to CO2 measured by arterial spin labeling after 6days at 4350m.
Villien M; Bouzat P; Rupp T; Robach P; Lamalle L; Troprès I; Estève F; Krainik A; Lévy P; Warnking JM; Verges S
Neuroimage; 2013 May; 72():272-9. PubMed ID: 23384523
[TBL] [Abstract][Full Text] [Related]
34. Cerebral diffusion and T(2): MRI predictors of acute mountain sickness during sustained high-altitude hypoxia.
Hunt JS; Theilmann RJ; Smith ZM; Scadeng M; Dubowitz DJ
J Cereb Blood Flow Metab; 2013 Mar; 33(3):372-80. PubMed ID: 23211961
[TBL] [Abstract][Full Text] [Related]
35. Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia.
Burtscher M; Flatz M; Faulhaber M
High Alt Med Biol; 2004; 5(3):335-40. PubMed ID: 15453999
[TBL] [Abstract][Full Text] [Related]
36. Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness?
Bailey DM; Taudorf S; Berg RM; Lundby C; McEneny J; Young IS; Evans KA; James PE; Shore A; Hullin DA; McCord JM; Pedersen BK; Möller K
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1283-92. PubMed ID: 19726713
[TBL] [Abstract][Full Text] [Related]
37. Acute mountain sickness, chemosensitivity, and cardiorespiratory responses in humans exposed to hypobaric and normobaric hypoxia.
Richard NA; Sahota IS; Widmer N; Ferguson S; Sheel AW; Koehle MS
J Appl Physiol (1985); 2014 Apr; 116(7):945-52. PubMed ID: 23823153
[TBL] [Abstract][Full Text] [Related]
38. Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals.
Faulhaber M; Pocecco E; Gatterer H; Niedermeier M; Huth M; Dünnwald T; Menz V; Bernardi L; Burtscher M
Med Sci Sports Exerc; 2016 Dec; 48(12):2563-2570. PubMed ID: 27414687
[TBL] [Abstract][Full Text] [Related]
39. Prediction of the susceptibility to AMS in simulated altitude.
Burtscher M; Szubski C; Faulhaber M
Sleep Breath; 2008 May; 12(2):103-8. PubMed ID: 18057977
[TBL] [Abstract][Full Text] [Related]
40. Altitude illness is related to low hypoxic chemoresponse and low oxygenation during sleep.
Nespoulet H; Wuyam B; Tamisier R; Saunier C; Monneret D; Remy J; Chabre O; Pépin JL; Lévy P
Eur Respir J; 2012 Sep; 40(3):673-80. PubMed ID: 22523356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
